- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 16:46 | FDA's new scheme to boost US manufacturing commences despite uncertainty | ||
| 13:46 | Sanofi touts strong new launch sales amid looming Dupixent patent expiry | ||
| 13:46 | AstraZeneca signs $18.5bn weight loss drug deal with CSPC | ||
| 12:46 | IQVIA and Boehringer Ingelheim collaborate on therapeutic data transformation | ||
| 11:46 | Repertoire and Lilly join hands on autoimmune disease therapies | ||
| Do | AstraZeneca pours $15bn into Chinese R&D and manufacturing operations | ||
| Do | Roche's 2025 profit blunted by weakened US dollar | ||
| Do | Sensorion announces $71.9m reserved offering to expand gene therapy pipeline | ||
| Do | FDA grants breakthrough status to Biogen's litifilimab for CLE | ||
| Mi | Eli Lilly outlays $1.12bn for hearing loss gene therapy partnership | ||
| Mi | CMS selects next batch of 15 high-cost medicines for third negotiation cycle | ||
| Mi | FDA accepts Otsuka's centanafadine application for ADHD treatment | ||
| Mi | Insilico and Qilu Pharmaceutical sign deal for cardiometabolic therapies | ||
| Di | UK and certain European countries lose WHO's measles-free status | ||
| Di | Mirum acquires Bluejay Therapeutics to expand rare liver disease pipeline | ||
| Di | FDA to review Eisai's Leqembi Iqlik sBLA for Alzheimer's | ||
| Mo | Internet of Medical Things beats AI as top ranked growth driver among life science CEOs | ||
| Mo | UK biotechs suffered restricted financing in 2025 | ||
| Mo | MSD ends takeover talks with Revolution Medicines | ||
| Mo | NICE greenlights Pfizer's Talzenna for NHS use | ||
| 23.01. | Corxel raises $287m as obesity continues to spark investor interest | ||
| 23.01. | Daiichi Sankyo and AstraZeneca's Enhertu gains NMPA approval for HER2 GEJ | ||
| 22.01. | BMS bets on Janux's novel solid tumour therapy through $850m deal | ||
| 22.01. | US set to officially exit WHO in culmination of Trump's domestic push | ||
| 22.01. | Heart disease and stroke deaths take a downturn, AHA report reveals |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.